Incyte Corporation (1INCY)
MTA
Real-time Data
07:00 AM
Day's Range
110.8052 wk Range
70.60Overview - 1INCY - Incyte Corporation
Key Statistics
Valuation
Enterprise Value
15.30B
P/E (Trailing)
‪16.47‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪3.85‬
Price / Book
‪4.08‬
EV / EBITDA
‪9.22‬
Profitability
Gross Margin
‪93.72%‬
Profit Margin
‪27.70%‬
Operating Margin
‪41.89%‬
Return on Assets
‪16.83%‬
Return on Equity
‪30.66%‬
Ownership
Shares Outstanding
200.97M
Float
170.73M
Held by Insiders
‪1.83%‬
Held by Institutions
‪103.83%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪101.79‬
200-Day Avg
‪89.11‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1INCY - Incyte Corporation
Peers - 1INCY - Incyte Corporation
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1INCYMTAIncyte Corporation17.89BMarket Cap+33.27%52-week change16.48P/E (Trailing)‪27.70%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+28.94%52-week change20.57P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)42.67BMarket Cap+47.15%52-week change140.57P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1INCY - Incyte Corporation
About
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics targeting hematology, oncology, inflammation, and autoimmunity. Its portfolio features key products such as JAKAFI (ruxolitinib), approved for intermediate or high-risk…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
